Program in Public Health, University of California, Irvine, California.
Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Am J Trop Med Hyg. 2020 Jun;102(6):1358-1365. doi: 10.4269/ajtmh.19-0907.
Effective case management is central for malaria control, but not all of those affected by malaria have access to prompt, effective treatment. In Kenya, free malaria treatment has been implemented since 2006. However, questions remain regarding effective treatment. We conducted cross-sectional epidemiological and questionnaire surveys in four counties in western Kenya in 2004, 2010, and 2016, and antimalarial availability surveys in 2016. We found a significant decline in self-reported malaria cases and an improvement in knowledge of malaria prevention and treatment since 2004. Parasite prevalence declined significantly from 2004 to 2010; however, it has remained unchanged since then. Artemisinin-based combination therapies (ACTs) and sulfadoxine-pyrimethamine (SP) drugs were widely available everywhere. The proportion of ACT usage increased from none in 2004 to 48% and 69%, respectively, in 2010 and 2016, whereas SP drug usage declined from 88% in 2004 to 39% in 2010 and 27% in 2016. During the 2016 survey, non-intermittent preventive treatment in pregnancy use of SP was common (20.9% of all surveyed individual treatments). In 2004, 27.2% (168/617) of households sought hospital treatment alone, and this number increased to 50.6% in 2016. The key factors affecting treatment-seeking behavior were education level, wealth index, household size, and distance to hospitals. Our results indicated that gaps in malaria case management remain and out-of-policy treatment is still a concern.
有效的病例管理是疟疾控制的核心,但并非所有受疟疾影响的人都能及时获得有效治疗。肯尼亚自 2006 年以来一直实施免费疟疾治疗。然而,对于有效治疗仍存在一些疑问。我们在 2004 年、2010 年和 2016 年在肯尼亚西部的四个县进行了横断面流行病学和问卷调查,以及 2016 年的抗疟药物可及性调查。我们发现,自 2004 年以来,自我报告的疟疾病例显著减少,对疟疾预防和治疗的认识有所提高。寄生虫患病率从 2004 年到 2010 年显著下降;然而,此后一直保持不变。青蒿素为基础的联合疗法(ACTs)和磺胺多辛-乙胺嘧啶(SP)药物在各地广泛供应。ACT 的使用率从 2004 年的无到 2010 年的 48%和 69%,而 SP 药物的使用率从 2004 年的 88%下降到 2010 年的 39%和 2016 年的 27%。在 2016 年的调查中,妊娠期间使用 SP 的间歇性预防治疗很常见(所有调查个体治疗的 20.9%)。2004 年,有 27.2%(617 户中的 168 户)的家庭只寻求医院治疗,这一数字在 2016 年增加到 50.6%。影响治疗寻求行为的关键因素是教育程度、财富指数、家庭规模和到医院的距离。我们的研究结果表明,疟疾病例管理仍存在差距,超出政策的治疗仍然是一个问题。